CoChat

Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus

Open access

The DOI matches its Crossref record; 18 of the 23 references it cites were found in a registry or an index.

Abstract

This study, a subgroup analysis of the data from the Organization Program of DiabEtes INsulIN ManaGement study, aimed to compare the efficacy and safety profiles of acarbose and metformin used in combination with premixed insulin.This analysis included 80 and 192 patients taking only 1 oral antidiabetic drug, classified into acarbose (treated with acarbose + insulin) and metformin groups (treated with metformin + insulin), respectively. The efficacy and safety data were analyzed for within- and between-group differences. The clinical trial registry number was NCT01338376.The percentage of patients who achieved target hemoglobin A1c (HbA1c) <7% in the acarbose and metformin groups were 38.75% and 30.73%, respectively, after a 16-week treatment. The average HbA1c levels in the acarbose and metformin groups were comparable at baseline and decreased significantly in both groups at the end of the study. All 7 blood glucose decreased significantly in both groups at endpoint compared with that at baseline. Insulin consumption was higher in the metformin group in terms of total daily amount and units/kg body weight. Incidences of hypoglycemia were similar in both groups. Body weight changed significantly in both groups from baseline to endpoint, but with no significant difference between the groups. Mean scores of Morisky Medication Adherence Scale improved in both groups at endpoint.Combination of insulin with acarbose or metformin could improve glycemic control in patients with type 2 diabetes mellitus. Acarbose and metformin were found to be comparable in terms of efficacy, weight gain, and incidence of hypoglycemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/md.0000000000007533

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Participant inclusion and exclusion processes. Aca = acarbose, Ins = premixed insulin, Met = metformin.
Figure 1 Participant inclusion and exclusion processes. Aca = acarbose, Ins = premixed insulin, Met = metformin.CC BY-ND · PubMed Central
Figure 2 Comparison of blood glucose levels at 7 time points before and after the treatment between the treatment groups. ∗P < .05 compared with the metformin group.
Figure 2 Comparison of blood glucose levels at 7 time points before and after the treatment between the treatment groups. ∗P < .05 compared with the metformin group.CC BY-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Research works printed but not linked: 1

  1. Lu, 2012, Glycaemic control in patients with type 2 diabetes treated with oral antidiabetic drugs in urban areas of China, Chin J Diabetes Mellitus, 4, 402

Cited by

See all 17

Metadata

Authors
Wu, H., Liu, J., Lou, Q., Liu, J., Shen, L., Zhang, M., Lv, X., Gu, M., & Guo, X.
Affiliations
  • Sir Run Run Shaw Hospital (CN)
  • Gansu Provincial Hospital (CN)
  • Peking University First Hospital (CN)
  • Peking University People's Hospital (CN)
  • Chinese PLA General Hospital (CN)
  • Shanghai Pudong New Area Gongli Hospital (CN)
Corresponding author
Guo, Xiaohui
Venue
Medicine
Published
2017-09
Volume
96
Issue
35
Pages
e7533
ISSN
0025-7974 (ISSN-L)
OpenAlex
W2751273963
Cited by
17
References
23
Citations by year
2026: 1 · 2025: 1 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 4 · 2018: 2
FWCI
1.51
Type
journal article
Language
en
Open access
Licence
cc-by-nd
Locations
  • Medicine (publishedVersion, cc-by-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nd)
  • PubMed Central (publishedVersion, cc-by-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
acarbose, metformin, premixed insulin, type 2 diabetes, glycemic control, HbA1c, hypoglycemia, insulin dose, body weight, medication adherence, oral antidiabetic drugs, insulin therapy
MeSH terms
Administration, Oral, Blood Glucose, China, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Injections, Subcutaneous, Insulin, Male, Metformin, Middle Aged, Treatment Outcome, Acarbose, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus. https://app.cochat.ai/papers/10.1097/md.0000000000007533
The paper
Wu, H., Liu, J., Lou, Q., Liu, J., Shen, L., Zhang, M., Lv, X., Gu, M., & Guo, X. (2017). Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus. Medicine. https://doi.org/10.1097/md.0000000000007533

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.